BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older

NCT02393898 · clinicaltrials.gov ↗

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Bevacizumab
DRUG: Carboplatin
DRUG: Paclitaxel

Sponsor

Hoffmann-La Roche